Clinical Trials Logo

Leishmaniasis; American clinical trials

View clinical trials related to Leishmaniasis; American.

Filter by:
  • None
  • Page 1

NCT ID: NCT03294161 Completed - Leishmaniasis Clinical Trials

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

Start date: December 2014
Phase: Phase 2
Study type: Interventional

A clinical trial to asses efficacy and safety of Transition-state Analog Inhibitor of Human Purine Nucleoside Phosphorylase for topical use associated standard antimonial in the treatment of Cutaneous Leishmaniasis in Bahia, Brazil.

NCT ID: NCT03096457 Completed - Clinical trials for Leishmaniasis, Cutaneous

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Start date: April 15, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This protocol will compare topical paromomycin to standard intralesional (IL) antimony (Sb) to placebo for L braziliensis in Bolivia.